{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T19:14:15Z","timestamp":1783710855789,"version":"3.55.0"},"reference-count":108,"publisher":"Xia & He Publishing","issue":"000","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,24]]},"DOI":"10.14218\/jcth.2021.00174","type":"journal-article","created":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T02:15:21Z","timestamp":1629771321000},"page":"000-000","source":"Crossref","is-referenced-by-count":3,"title":["Nonalcoholic Fatty Liver Disease (NAFLD) Name Change: Requiem or Reveille?"],"prefix":"10.14218","volume":"000","author":[{"given":"Shivaram P.","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prajna","family":"Anirvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reshu","family":"Khandelwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjaya K.","family":"Satapathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5334","published-online":{"date-parts":[[2021,8,24]]},"reference":[{"issue":"7","key":"key20210824021515_JCTH-D-21-00174-b1","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"key20210824021515_JCTH-D-21-00174-b2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"issue":"4","key":"key20210824021515_JCTH-D-21-00174-b3","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jhep.2020.12.025","article-title":"Yet more evidence that MAFLD is more than name change","volume":"74","author":"Eslam","year":"2021","journal-title":"J Hepatol"},{"issue":"12","key":"key20210824021515_JCTH-D-21-00174-b4","doi-asserted-by":"crossref","first-page":"e3875","DOI":"10.1371\/journal.pone.0003875","article-title":"The role of medical language in changing public perceptions of illness","volume":"3","author":"Young","year":"2008","journal-title":"PLoS One"},{"issue":"3","key":"key20210824021515_JCTH-D-21-00174-b5","doi-asserted-by":"crossref","first-page":"115047","DOI":"10.1016\/j.diagmicrobio.2020.115047","article-title":"Proposed nomenclature or classification changes for bacteria of medical importance: taxonomic update 5","volume":"97","author":"Janda","year":"2020","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key20210824021515_JCTH-D-21-00174-b6","unstructured":"WHO | WHO issues best practices for naming new human infectious diseases. WHO. Available from: https:\/\/www.who.int\/mediacentre\/news\/notes\/2015\/naming-new-diseases\/en\/"},{"issue":"5","key":"key20210824021515_JCTH-D-21-00174-b7","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/hep.510360543","article-title":"Leave gourmandising","volume":"36","author":"Reuben","year":"2002","journal-title":"Hepatology"},{"issue":"3","key":"key20210824021515_JCTH-D-21-00174-b8","first-page":"347","article-title":"Fatty infiltration of the liver and the development of cirrhosis in diabetes and chronic alcoholism","volume":"14","author":"Connor","year":"1938","journal-title":"Am J Pathol"},{"issue":"4","key":"key20210824021515_JCTH-D-21-00174-b9","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0016-5085(58)80054-2","article-title":"Liver impairment in the obese","volume":"34","author":"Westwater","year":"1958","journal-title":"Gastroenterology"},{"issue":"5","key":"key20210824021515_JCTH-D-21-00174-b10","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0002-9343(79)90740-X","article-title":"Fatty liver hepatitis and cirrhosis in obese patients","volume":"67","author":"Adler","year":"1979","journal-title":"Am J Med"},{"issue":"7","key":"key20210824021515_JCTH-D-21-00174-b11","first-page":"434","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"key20210824021515_JCTH-D-21-00174-b12","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0884533611419668","article-title":"Nonalcoholic fatty liver disease: a review of the spectrum of disease, diagnosis, and therapy","volume":"26","author":"Kopec","year":"2011","journal-title":"Nutr Clin Pract"},{"issue":"5","key":"key20210824021515_JCTH-D-21-00174-b13","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.1840120505","article-title":"Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors","volume":"12","author":"Wanless","year":"1990","journal-title":"Hepatol Baltim Md"},{"issue":"1","key":"key20210824021515_JCTH-D-21-00174-b14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.0954-6820.1986.tb02733.x","article-title":"Nonalcoholic steatohepatitis in obesity: a reversible condition","volume":"220","author":"Eriksson","year":"1986","journal-title":"Acta Med Scand"},{"issue":"4","key":"key20210824021515_JCTH-D-21-00174-b15","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0016-5085(94)90235-6","article-title":"Nonalcoholic steatohepatitis: an expanded clinical entity","volume":"107","author":"Bacon","year":"1994","journal-title":"Gastroenterology"},{"issue":"8","key":"key20210824021515_JCTH-D-21-00174-b16","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.2337\/diacare.27.8.2057","article-title":"Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis","volume":"27","author":"Medina","year":"2004","journal-title":"Diabetes Care"},{"issue":"1","key":"key20210824021515_JCTH-D-21-00174-b17","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatol Baltim Md"},{"key":"key20210824021515_JCTH-D-21-00174-b18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.metabol.2019.05.001","article-title":"Fatty liver in lipodystrophy: a review with a focus on therapeutic perspectives of adiponectin and\/or leptin replacement","volume":"96","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"issue":"11","key":"key20210824021515_JCTH-D-21-00174-b19","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3748\/wjg.v24.i11.1269","article-title":"Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals","volume":"24","author":"Noureddin","year":"2018","journal-title":"World J Gastroenterol"},{"key":"key20210824021515_JCTH-D-21-00174-b20","unstructured":"Tetracycline. In: LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. National Institute of Diabetes and Digestive and Kidney Diseases; 2012. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK547920\/"},{"issue":"2","key":"key20210824021515_JCTH-D-21-00174-b21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0016-5085(19)32597-1","article-title":"Reye\u2019s syndrome (encephalopathy and fatty liver). Diagnosis and treatment","volume":"69","author":"Partin","year":"1975","journal-title":"Gastroenterology"},{"issue":"1","key":"key20210824021515_JCTH-D-21-00174-b22","doi-asserted-by":"crossref","first-page":"10222","DOI":"10.1038\/srep10222","article-title":"Chronic inflammation aggravates metabolic disorders of hepatic fatty acids in high-fat diet-induced obese mice","volume":"5","author":"Zhao","year":"2015","journal-title":"Sci Rep"},{"issue":"6","key":"key20210824021515_JCTH-D-21-00174-b23","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.jhep.2016.05.046","article-title":"Malnutrition-associated liver steatosis and ATP depletion is caused by peroxisomal and mitochondrial dysfunction","volume":"65","author":"van Zutphen","year":"2016","journal-title":"J Hepatol"},{"issue":"2","key":"key20210824021515_JCTH-D-21-00174-b24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jgh3.12044","article-title":"Prevalence and risk factors of non-alcoholic fatty liver disease in Bangladesh","volume":"2","author":"Alam","year":"2018","journal-title":"JGH Open"},{"issue":"4","key":"key20210824021515_JCTH-D-21-00174-b25","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.clinre.2014.08.014","article-title":"Nonalcoholic fatty liver disease (NAFLD) without insulin resistance: is it different?","volume":"39","author":"Singh","year":"2015","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"2","key":"key20210824021515_JCTH-D-21-00174-b26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3329\/bccj.v4i2.30022","article-title":"Insulin resistance in nonalcoholic fatty liver disease: experience from Bangladesh","volume":"4","author":"Azam","year":"2016","journal-title":"Bangladesh Crit Care J"},{"key":"key20210824021515_JCTH-D-21-00174-b27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.metabol.2016.06.009","article-title":"Non-alcoholic fatty liver disease with and without metabolic syndrome: different long-term outcomes","volume":"66","author":"K\u00e4r\u00e4j\u00e4m\u00e4ki","year":"2017","journal-title":"Metabolism"},{"issue":"5","key":"key20210824021515_JCTH-D-21-00174-b28","first-page":"65","article-title":"Preclinical cardiac disease in nonalcoholic fatty liver disease with and without metabolic syndrome","volume":"9","author":"Makker","year":"2019","journal-title":"Am J Cardiovasc Dis"},{"issue":"4","key":"key20210824021515_JCTH-D-21-00174-b29","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s00125-013-2829-9","article-title":"Adipose tissue is inflamed in NAFLD due to obesity but not in NAFLD due to genetic variation in PNPLA3","volume":"56","author":"Lallukka","year":"2013","journal-title":"Diabetologia"},{"issue":"4","key":"key20210824021515_JCTH-D-21-00174-b30","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1161\/01.ATV.0000116217.57583.6e","article-title":"Hepatic steatosis: a mediator of the metabolic syndrome. lessons from animal models","volume":"24","author":"den Boer","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"key20210824021515_JCTH-D-21-00174-b31","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/0046-8177(89)90249-9","article-title":"Nonalcoholic steatohepatitis: a study of 49 patients","volume":"20","author":"Lee","year":"1989","journal-title":"Hum Pathol"},{"issue":"6","key":"key20210824021515_JCTH-D-21-00174-b32","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.clnu.2012.05.011","article-title":"The evolutionary benefit of insulin resistance","volume":"31","author":"Soeters","year":"2012","journal-title":"Clin Nutr Edinb Scotl"},{"issue":"5","key":"key20210824021515_JCTH-D-21-00174-b33","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.metabol.2012.11.004","article-title":"Insulin resistance: an adaptive mechanism becomes maladaptive in the current environment\u2014an evolutionary perspective","volume":"62","author":"Tsatsoulis","year":"2013","journal-title":"Metab - Clin Exp"},{"issue":"13","key":"key20210824021515_JCTH-D-21-00174-b34","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.clinbiochem.2009.05.018","article-title":"Hepatic insulin resistance, metabolic syndrome and cardiovascular disease","volume":"42","author":"Meshkani","year":"2009","journal-title":"Clin Biochem"},{"issue":"13","key":"key20210824021515_JCTH-D-21-00174-b35","doi-asserted-by":"crossref","first-page":"7522","DOI":"10.1073\/pnas.121164498","article-title":"Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance","volume":"98","author":"Kim","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"31","key":"key20210824021515_JCTH-D-21-00174-b36","doi-asserted-by":"crossref","first-page":"32345","DOI":"10.1074\/jbc.M313478200","article-title":"Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease","volume":"279","author":"Samuel","year":"2004","journal-title":"J Biol Chem"},{"issue":"38","key":"key20210824021515_JCTH-D-21-00174-b37","doi-asserted-by":"crossref","first-page":"E8996","DOI":"10.1073\/pnas.1804379115","article-title":"PKC\u03b5 contributes to lipid-induced insulin resistance through cross talk with p70S6K and through previously unknown regulators of insulin signaling","volume":"115","author":"Gassaway","year":"2018","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"key20210824021515_JCTH-D-21-00174-b38","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.cmet.2012.03.005","article-title":"Diacylglycerol activation of protein kinase C\u03b5 and hepatic insulin resistance","volume":"15","author":"Jornayvaz","year":"2012","journal-title":"Cell Metab"},{"issue":"1","key":"key20210824021515_JCTH-D-21-00174-b39","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cmet.2007.05.005","article-title":"Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver","volume":"6","author":"Monetti","year":"2007","journal-title":"Cell Metab"},{"issue":"5","key":"key20210824021515_JCTH-D-21-00174-b40","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1073\/pnas.1219456110","article-title":"CGI-58 knockdown sequesters diacylglycerols in lipid droplets\/ER-preventing diacylglycerol-mediated hepatic insulin resistance","volume":"110","author":"Cantley","year":"2013","journal-title":"Proc Natl Acad Sci"},{"issue":"39","key":"key20210824021515_JCTH-D-21-00174-b41","doi-asserted-by":"crossref","first-page":"16381","DOI":"10.1073\/pnas.1113359108","article-title":"Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease","volume":"108","author":"Kumashiro","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"key20210824021515_JCTH-D-21-00174-b42","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.tips.2017.04.004","article-title":"Roles of diacylglycerols and ceramides in hepatic insulin resistance","volume":"38","author":"Petersen","year":"2017","journal-title":"Trends Pharmacol Sci"},{"key":"key20210824021515_JCTH-D-21-00174-b43","first-page":"361","article-title":"Activation of conventional and novel protein kinase C isozymes by different diacylglycerol molecular species","volume":"7","author":"Kamiya","year":"2016","journal-title":"Biochem Biophys Rep"},{"issue":"11","key":"key20210824021515_JCTH-D-21-00174-b44","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.2337\/db09-0279","article-title":"Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene","volume":"58","author":"Kantartzis","year":"2009","journal-title":"Diabetes"},{"issue":"5","key":"key20210824021515_JCTH-D-21-00174-b45","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jhep.2008.12.025","article-title":"Genetic factors contribute to variation in serum alanine aminotransferase activity independent of obesity and alcohol: a study in monozygotic and dizygotic twins","volume":"50","author":"Makkonen","year":"2009","journal-title":"J Hepatol"},{"issue":"1","key":"key20210824021515_JCTH-D-21-00174-b46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0002-9343(99)00315-0","article-title":"Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds","volume":"108","author":"Struben","year":"2000","journal-title":"Am J Med"},{"issue":"Suppl 6","key":"key20210824021515_JCTH-D-21-00174-b47","doi-asserted-by":"crossref","first-page":"s77","DOI":"10.7861\/clinmedicine.15-6-s77","article-title":"An overview of the genetics, mechanisms and management of NAFLD and ALD","volume":"15","author":"Rowell","year":"2015","journal-title":"Clin Med Lond Engl"},{"issue":"12","key":"key20210824021515_JCTH-D-21-00174-b48","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat Genet"},{"issue":"17","key":"key20210824021515_JCTH-D-21-00174-b49","doi-asserted-by":"crossref","first-page":"7892","DOI":"10.1073\/pnas.1003585107","article-title":"A feed-forward loop amplifies nutritional regulation of PNPLA3","volume":"107","author":"Huang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"key20210824021515_JCTH-D-21-00174-b50","doi-asserted-by":"crossref","first-page":"6706","DOI":"10.1074\/jbc.M109.064501","article-title":"A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis","volume":"285","author":"He","year":"2010","journal-title":"J Biol Chem"},{"key":"key20210824021515_JCTH-D-21-00174-b51","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2147\/HMER.S125718","article-title":"PNPLA3 expression and its impact on the liver: current perspectives","volume":"9","author":"Bruschi","year":"2017","journal-title":"Hepatic Med Evid Res"},{"issue":"29","key":"key20210824021515_JCTH-D-21-00174-b52","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.2174\/13816128113199990381","article-title":"Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment","volume":"19","author":"Dongiovanni","year":"2013","journal-title":"Curr Pharm Des"},{"issue":"9","key":"key20210824021515_JCTH-D-21-00174-b53","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.2337\/db08-0422","article-title":"Evaluating the role of LPIN1 variation in insulin resistance, body weight, and human lipodystrophy in U.K. Populations","volume":"57","author":"Fawcett","year":"2008","journal-title":"Diabetes"},{"issue":"9","key":"key20210824021515_JCTH-D-21-00174-b54","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/j.1440-1746.2008.05523.x","article-title":"A Val227Ala substitution in the peroxisome proliferator activated receptor alpha (PPAR alpha) gene associated with non-alcoholic fatty liver disease and decreased waist circumference and waist-to-hip ratio","volume":"23","author":"Chen","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"key20210824021515_JCTH-D-21-00174-b55","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1038\/ncomms5309","article-title":"TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease","volume":"5","author":"Liu","year":"2014","journal-title":"Nat Commun"},{"issue":"4","key":"key20210824021515_JCTH-D-21-00174-b56","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/hep.26225","article-title":"Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis","volume":"57","author":"Bechmann","year":"2013","journal-title":"Hepatol Baltim Md"},{"issue":"3","key":"key20210824021515_JCTH-D-21-00174-b57","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.metabol.2010.03.006","article-title":"Plasma metabolomic profile in nonalcoholic fatty liver disease","volume":"60","author":"Kalhan","year":"2011","journal-title":"Metabolism"},{"issue":"5418","key":"key20210824021515_JCTH-D-21-00174-b58","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"issue":"46","key":"key20210824021515_JCTH-D-21-00174-b59","doi-asserted-by":"crossref","first-page":"45062","DOI":"10.1074\/jbc.M307145200","article-title":"Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity","volume":"278","author":"Guo","year":"2003","journal-title":"J Biol Chem"},{"key":"key20210824021515_JCTH-D-21-00174-b60","doi-asserted-by":"crossref","first-page":"934396","DOI":"10.1155\/2012\/934396","article-title":"Non-alcoholic fatty liver disease: the bile acid-activated farnesoid X receptor as an emerging treatment target","volume":"2012","author":"Fuchs","year":"2012","journal-title":"J Lipids"},{"key":"key20210824021515_JCTH-D-21-00174-b61","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1101\/sqb.2011.76.010710","article-title":"Roles of FGF19 in liver metabolism","volume":"76","author":"Kir","year":"2011","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"5","key":"key20210824021515_JCTH-D-21-00174-b62","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/hep.22519","article-title":"Farnesoid X receptor antagonizes nuclear factor \u03baB in hepatic inflammatory response","volume":"48","author":"Wang","year":"2008","journal-title":"Hepatology"},{"key":"key20210824021515_JCTH-D-21-00174-b63","doi-asserted-by":"crossref","article-title":"Increased serum total bile acid is independently associated with non-alcoholic steatohepatitis in non-diabetes population","author":"Li","DOI":"10.21203\/rs.3.rs-27123\/v1"},{"issue":"12","key":"key20210824021515_JCTH-D-21-00174-b64","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.3390\/nu6125583","article-title":"The role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver disease","volume":"6","author":"Ferolla","year":"2014","journal-title":"Nutrients"},{"issue":"7341","key":"key20210824021515_JCTH-D-21-00174-b65","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"issue":"3","key":"key20210824021515_JCTH-D-21-00174-b66","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1002\/jcb.27635","article-title":"Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probiotics","volume":"120","author":"Chen","year":"2019","journal-title":"J Cell Biochem"},{"issue":"2","key":"key20210824021515_JCTH-D-21-00174-b67","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s40495-017-0085-2","article-title":"Role of FXR in liver inflammation during nonalcoholic steatohepatitis","volume":"3","author":"Armstrong","year":"2017","journal-title":"Curr Pharmacol Rep"},{"issue":"1","key":"key20210824021515_JCTH-D-21-00174-b68","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/hep.28709","article-title":"Bile acids and nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives","volume":"65","author":"Arab","year":"2017","journal-title":"Hepatol Baltim Md"},{"issue":"7","key":"key20210824021515_JCTH-D-21-00174-b69","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1136\/gutjnl-2016-311571","article-title":"Gut microbiota produce alcohol and contribute to NAFLD","volume":"65","author":"Zhu","year":"2016","journal-title":"Gut"},{"issue":"1","key":"key20210824021515_JCTH-D-21-00174-b70","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/s41598-018-19753-9","article-title":"Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance","volume":"8","author":"Da Silva","year":"2018","journal-title":"Sci Rep"},{"key":"key20210824021515_JCTH-D-21-00174-b71","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-981-10-8684-7_7","article-title":"Dysregulated epigenetic modifications in the pathogenesis of NAFLD-HCC","volume":"1061","author":"Zhao","year":"2018","journal-title":"Adv Exp Med Biol"},{"issue":"36","key":"key20210824021515_JCTH-D-21-00174-b72","doi-asserted-by":"crossref","first-page":"e1480","DOI":"10.1097\/MD.0000000000001480","article-title":"Epigenetic modifications in the biology of nonalcoholic fatty liver disease: the role of DNA hydroxymethylation and TET proteins","volume":"94","author":"Pirola","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"key20210824021515_JCTH-D-21-00174-b73","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13148-015-0056-6","article-title":"Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease","volume":"7","author":"Zeybel","year":"2015","journal-title":"Clin Epigenetics"},{"issue":"11","key":"key20210824021515_JCTH-D-21-00174-b74","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1136\/gutjnl-2015-311292","article-title":"Epigenetics in liver disease: from biology to therapeutics","volume":"65","author":"Hardy","year":"2016","journal-title":"Gut"},{"issue":"2","key":"key20210824021515_JCTH-D-21-00174-b75","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jhep.2015.02.049","article-title":"Targeted-bisulfite sequence analysis of the methylation of CpG islands in genes encoding PNPLA3, SAMM50, and PARVB of patients with non-alcoholic fatty liver disease","volume":"63","author":"Kitamoto","year":"2015","journal-title":"J Hepatol"},{"issue":"6","key":"key20210824021515_JCTH-D-21-00174-b76","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/nm.2744","article-title":"Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration","volume":"18","author":"Sun","year":"2012","journal-title":"Nat Med"},{"key":"key20210824021515_JCTH-D-21-00174-b77","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3389\/fphys.2019.00682","article-title":"New insights into the circadian rhythm and its related diseases","volume":"10","author":"Xie","year":"2019","journal-title":"Front Physiol"},{"issue":"1-2","key":"key20210824021515_JCTH-D-21-00174-b78","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.autneu.2011.03.002","article-title":"Systemic inflammation and circadian rhythm of cardiac autonomic modulation","volume":"162","author":"Li","year":"2011","journal-title":"Auton Neurosci Basic Clin"},{"issue":"1","key":"key20210824021515_JCTH-D-21-00174-b79","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1038\/s41598-020-59541-y","article-title":"Chronic circadian misalignment accelerates immune senescence and abbreviates lifespan in mice","volume":"10","author":"Inokawa","year":"2020","journal-title":"Sci Rep"},{"issue":"6","key":"key20210824021515_JCTH-D-21-00174-b80","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00109-019-01780-2","article-title":"Circadian rhythms: a possible new player in non-alcoholic fatty liver disease pathophysiology","volume":"97","author":"Gnocchi","year":"2019","journal-title":"J Mol Med"},{"issue":"8","key":"key20210824021515_JCTH-D-21-00174-b81","doi-asserted-by":"crossref","first-page":"8625","DOI":"10.18632\/oncotarget.7065","article-title":"Evolving roles of circadian rhythms in liver homeostasis and pathology","volume":"7","author":"Zhou","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"key20210824021515_JCTH-D-21-00174-b82","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrgastro.2016.8","article-title":"Circadian rhythms of liver physiology and disease: experimental and clinical evidence","volume":"13","author":"Tahara","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8","key":"key20210824021515_JCTH-D-21-00174-b83","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/ijo.2012.180","article-title":"Differences in circadian rhythmicity in CLOCK 3111T\/C genetic variants in moderate obese women as assessed by thermometry, actimetry and body position","volume":"37","author":"Band\u00edn","year":"2013","journal-title":"Int J Obes (Lond)"},{"issue":"8","key":"key20210824021515_JCTH-D-21-00174-b84","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/liv.12534","article-title":"Non-alcoholic fatty liver disease: the role of nuclear receptors and circadian rhythmicity","volume":"34","author":"Mazzoccoli","year":"2014","journal-title":"Liver Int"},{"key":"key20210824021515_JCTH-D-21-00174-b85","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-4-431-55651-0_2","article-title":"Metabolic regulation by nuclear receptors","volume-title":"Innovative Medicine","author":"Liu","year":"2015"},{"issue":"2","key":"key20210824021515_JCTH-D-21-00174-b86","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nsmb.2476","article-title":"Nuclear receptor corepressors are required for the histone deacetylase activity of HDAC3 in vivo","volume":"20","author":"You","year":"2013","journal-title":"Nat Struct Mol Biol"},{"issue":"3","key":"key20210824021515_JCTH-D-21-00174-b87","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.cr.7310149","article-title":"HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics","volume":"17","author":"Gallinari","year":"2007","journal-title":"Cell Res"},{"issue":"6022","key":"key20210824021515_JCTH-D-21-00174-b88","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1126\/science.1198125","article-title":"A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism","volume":"331","author":"Feng","year":"2011","journal-title":"Science"},{"issue":"8","key":"key20210824021515_JCTH-D-21-00174-b89","doi-asserted-by":"crossref","first-page":"e6843","DOI":"10.1371\/journal.pone.0006843","article-title":"Circadian dysregulation disrupts bile acid homeostasis","volume":"4","author":"Ma","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"key20210824021515_JCTH-D-21-00174-b90","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/ejcn.2017.148","article-title":"Associations between dietary factors and markers of NAFLD in a general Dutch adult population","volume":"72","author":"Rietman","year":"2018","journal-title":"Eur J Clin Nutr"},{"issue":"6","key":"key20210824021515_JCTH-D-21-00174-b91","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.clnu.2016.09.034","article-title":"Association between rice, bread, and noodle intake and the prevalence of non-alcoholic fatty liver disease in Japanese middle-aged men and women","volume":"36","author":"Tajima","year":"2017","journal-title":"Clin Nutr Edinb Scotl"},{"issue":"10","key":"key20210824021515_JCTH-D-21-00174-b92","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1155\/2008\/810961","article-title":"Soft drink consumption linked with fatty liver in the absence of traditional risk factors","volume":"22","author":"Assy","year":"2008","journal-title":"Can J Gastroenterol"},{"issue":"5","key":"key20210824021515_JCTH-D-21-00174-b93","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jhep.2009.05.033","article-title":"Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome","volume":"51","author":"Abid","year":"2009","journal-title":"J Hepatol"},{"issue":"5","key":"key20210824021515_JCTH-D-21-00174-b94","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/hep.23516","article-title":"Cigarette smoking exacerbates nonalcoholic fatty liver disease in obese rats","volume":"51","author":"Azzalini","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"key20210824021515_JCTH-D-21-00174-b95","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41395-018-0283-5","article-title":"Smoking and the risk of non-alcoholic fatty liver disease: a cohort study","volume":"114","author":"Jung","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"key20210824021515_JCTH-D-21-00174-b96","first-page":"1007","article-title":"Relationship between diet and non-alcoholic fatty liver disease: a review article","volume":"46","author":"Mirmiran","year":"2017","journal-title":"Iran J Public Health"},{"issue":"3","key":"key20210824021515_JCTH-D-21-00174-b97","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1136\/jamia.2000.0070298","article-title":"Clinical classification and terminology","volume":"7","author":"Chute","year":"2000","journal-title":"J Am Med Inform Assoc"},{"issue":"10091","key":"key20210824021515_JCTH-D-21-00174-b98","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0140-6736(16)32407-2","article-title":"Non-Hodgkin lymphoma","volume":"390","author":"Armitage","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"key20210824021515_JCTH-D-21-00174-b99","first-page":"972","article-title":"Non-alcoholic fatty liver disease: not time for an obituary just yet!","volume":"74","author":"Singh","year":"2021"},{"issue":"3","key":"key20210824021515_JCTH-D-21-00174-b100","doi-asserted-by":"crossref","first-page":"288","DOI":"10.21037\/tlcr.2016.06.07","article-title":"Non-small cell lung cancer: current treatment and future advances","volume":"5","author":"Zappa","year":"2016","journal-title":"Transl Lung Cancer Res"},{"key":"key20210824021515_JCTH-D-21-00174-b101","article-title":"The Rome III criteria for the diagnosis of functional dyspepsia in secondary care are not superior to previous definitions","author":"Ford","journal-title":"Gastroenterology 2014;146(4):932-940,quiz e14-15"},{"issue":"1","key":"key20210824021515_JCTH-D-21-00174-b102","doi-asserted-by":"crossref","first-page":"e000359","DOI":"10.1136\/bmjgast-2019-000359","article-title":"Changes in metabolic complications in patients with alcoholic fatty liver disease monitored over two decades: NAGALA study","volume":"7","author":"Hamaguchi","year":"2020","journal-title":"BMJ Open Gastroenterol"},{"issue":"4","key":"key20210824021515_JCTH-D-21-00174-b103","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrgastro.2015.35","article-title":"Alcoholic liver disease: mechanisms of injury and targeted treatment","volume":"12","author":"Louvet","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"key20210824021515_JCTH-D-21-00174-b104","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1053\/j.gastro.2013.11.008","article-title":"Deletion of SIRT1 from hepatocytes in mice disrupts Lipin-1 signaling and aggravates alcoholic fatty liver","volume":"146","author":"Yin","year":"2014","journal-title":"Gastroenterology"},{"issue":"3","key":"key20210824021515_JCTH-D-21-00174-b105","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1053\/j.gastro.2003.12.008","article-title":"Pioglitazone prevents alcohol-induced fatty liver in rats through upregulation of c-Met","volume":"126","author":"Tomita","year":"2004","journal-title":"Gastroenterology"},{"issue":"1","key":"key20210824021515_JCTH-D-21-00174-b106","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/hepr.12333","article-title":"Diagnosis and classification of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: current concepts and remaining challenges","volume":"45","author":"Hashimoto","year":"2015","journal-title":"Hepatol Res"},{"issue":"2","key":"key20210824021515_JCTH-D-21-00174-b107","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/liv.14739","article-title":"The NAFLD-MAFLD debate: eminence vs evidence","volume":"41","author":"Fouad","year":"2021","journal-title":"Liver Int"},{"issue":"12","key":"key20210824021515_JCTH-D-21-00174-b108","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1111\/liv.14675","article-title":"MAFLD identifies patients with significant hepatic fibrosis better than NAFLD","volume":"40","author":"Yamamura","year":"2020","journal-title":"Liver Int"}],"container-title":["Journal of Clinical and Translational Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.xiahepublishing.com\/2310-8819\/JCTH-2021-00174","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:20:07Z","timestamp":1783707607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.xiahepublishing.com\/2310-8819\/JCTH-2021-00174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,24]]},"references-count":108,"journal-issue":{"issue":"000","published-online":{"date-parts":[[2021,8,24]]},"published-print":{"date-parts":[[2021,8,24]]}},"alternative-id":["10.14218\/JCTH.2021.00174"],"URL":"https:\/\/doi.org\/10.14218\/jcth.2021.00174","relation":{},"ISSN":["2225-0719","2310-8819"],"issn-type":[{"value":"2225-0719","type":"print"},{"value":"2310-8819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,24]]}}}